Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Contrast Agent Cross-Drug Open-House Procedure for the Kv Region of Mecklenburg-Western Pomerania

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Adalimumab, Atc Code: L04ab04 for the Period from April 1St, 2023 to March 31St, 2025

Dps Qualification for Blood Gas Analysers/Accessories and Associated Service Provision

Conclusion of Non-Exclusive Discount Agreements According to § 130A Abs. 8 Sgb V for the Active Ingredient Mepolizumab

Conclusion of Non-Exclusive Discount Agreements According to § 130A Paragraph 8 Sgb V for the Active Ingredient Rotigotine

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Infliximab

Open House Biologics Rebate Agreements 2023-03 - Interferon Beta-1A (Prepared Drug Name: Avonex(R))

Conclusion of Non-Exclusive Discount Agreements According to Section 130A Paragraph 8 Sgb V for the Active Ingredient Certolizumab Pegol

Nhs Generic Pharmaceuticals - Wave 15B - Dce & Dsw

Nhs Generic Pharmaceuticals - Wave 15C - Dls & Dne